IP Library › Granted Patent US 11,535,854
Granted Patent B2
US 11,535,854 · App. 16/612,300 · Granted Dec 27, 2022

Microorganism strain for high-performance metabolism of biomass-derived carbon source

Inventors: Gyoo Yeol Jung (Gyeongsangbuk-do, KR); Dong Hun Kwak (Chungcheongbuk-do, KR); Sang Woo Seo (Seoul, KR); Hyun Gyu Lim (Gyeongsangbuk-do, KR)
Assignees: POSTECH ACADEMY-INDUSTRY FOUNDATION; SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION
C12N15/74C12N1/20C12P7/16C12N1/205C12R2001/63C12Y306/03001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,535,854
App. No.
16/612,300
Granted
Dec 27, 2022
Kind
B2
Abstract

The present invention relates to a novel microorganism capable of metabolizing various carbon sources at high rates. A novel microorganism according to the present invention was observed to grow at a very high rate in a minimal medium/nutrient medium, etc., compared to microorganisms such as Escherichia coli , and shows resistance at a high initial sugar/salt concentrations as well as being able to produce lycopene and 2,3-butanediol through genetic manipulation. Therefore, the novel microorganism can be used in various production fields of high value-added compounds using microorganisms.

Claims (27)

1. A transformed Vibrio sp. DHG strain with improved metabolic efficiency for carbon sources,

wherein the transformed Vibrio sp. DHG strain is obtained by introducing a SXT recombination system expression cassette into a Vibrio sp. DHG strain having accession number KCTC13239BP;

wherein the Vibrio sp. DHG strain having accession number KCTC13239BP comprises a 16S rDNA gene consisting of the nucleotide sequence of SEQ ID NO: 1;

wherein the SXT recombination system expression cassette comprises a synthetic 5′ UTR (untranslated region) consisting of the nucleotide sequence of SEQ ID NO: 57; a promoter consisting of the nucleotide sequence selected from the group consisting of SEQ ID NOs: 22 to 35 and 56; and a gamma gene consisting of the nucleotide sequence of SEQ ID NO: 6; and

wherein the carbon source comprises at least one selected from the group consisting of glucose, mannitol, sucrose, arabinose, galactose, glycerol and alginic acid.

2. The transformed Vibrio sp. DHG strain of claim 1 ,

wherein the Vibrio sp. DHG strain having accession number KCTC13239BP comprises a beta gene consisting of the nucleotide sequence of SEQ ID NO: 3 or a beta protein consisting of the amino acid sequence of SEQ ID NO: 2.

3. The transformed Vibrio sp. DHG strain of claim 1 ,

wherein the Vibrio sp. DHG strain having accession number KCTC13239BP comprises an exo gene consisting of the nucleotide sequence of SEQ ID NO: 5 or an exo protein consisting of the amino acid sequence of SEQ ID NO: 4.

4. A transformed strain for lycopene production,

wherein a crtEBI gene consisting of the nucleotide sequence of SEQ ID NO: 9 is further introduced to the transformed Vibrio sp. DHG strain of claim 1 .

5. The transformed strain for lycopene production of claim 4 , wherein an idi gene consisting of the nucleotide sequence of SEQ ID NO: 10 is further introduced thereinto.

6. The transformed strain for lycopene production of claim 4 , wherein an ispA gene consisting of the nucleotide sequence of SEQ ID NO: 11 is further introduced thereinto.

7. The transformed strain for lycopene production of claim 4 , wherein a dxs gene consisting of the nucleotide sequence of SEQ ID NO: 12 is further introduced thereinto.

8. A transformed strain for producing 2,3-butanediol, wherein the transformed strain is obtained by introducing, into the transformed Vibrio sp. DHG strain of claim 1 , at least one gene selected from the group consisting of:

a budA gene consisting of the nucleotide sequence of SEQ ID NO: 13;

a budB gene consisting of the nucleotide sequence of SEQ ID NO: 14; and

a budC gene consisting of the nucleotide sequence of SEQ ID NO: 15.

9. The transformed strain for producing 2,3-butanediol of claim 8 , wherein the transformed strain is obtained by deleting, from the transformed Vibrio sp. DHG strain, at least one gene selected from the group consisting of:

a IdhA gene consisting of the nucleotide sequence of SEQ ID NO: 16;

a frdA gene consisting of the nucleotide sequence of SEQ ID NO: 17;

a frdB gene consisting of the nucleotide sequence of SEQ ID NO: 18;

a frdC gene consisting of the nucleotide sequence of SEQ ID NO: 19;

a frdD gene consisting of the nucleotide sequence of SEQ ID NO: 20;

a pflB gene consisting of the nucleotide sequence of SEQ ID NO: 21.

10. A method of producing lycopene, the method comprising culturing the transformed strain for lycopene production of claim 4 .

11. A method for producing 2,3-butanediol, the method comprising culturing the transformed strain for producing 2,3-butanediol of claim 8 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2019
From: JUNG, GYOO YEOL; KWAK, DONG HUN; SEO, SANG WOO; LIM, HYUN GYU
To: POSTECH ACADEMY-INDUSTRY FOUNDATION; SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION
Reel/Frame 051054/0737 →
Priority Claims (1)
KR 10-2017-0058781 · May 11, 2017 · national
Continuity (1)
Related Publication 20200354755A1 · Nov 12, 2020